Skip to content

Evaluation of the effect and safety of fractional PDL and CO2 lasers on burn scars

Evaluation of the efficacy and safety of co2 fractional laser in combination with Pulsed dye laser vs. each one alone in treatment of hypertrophic burn scars: a blinded RCT

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201005048928N1
Enrollment
60
Registered
2022-07-05
Start date
2021-02-27
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

treatment of hypertrophic or keloidal burn scars.

Interventions

Intervention 1: Control group: Patients in the control group receive a PDL laser with a pulse of 595 nm in first treatment session and this treatment is repeated for up to 3 sessions. The interval bet

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients with hypertrophic scars caused by burn

Exclusion criteria

Exclusion criteria: Women who are included in the study should not breastfeed Women who are included in the study should not be pregnant Study participants should not have used lasers for the past 1 month. Study participants should not have used topical or injectable corticosteroids in the past 1 month ?Study participants shouldn't have underlying diseases that interfere with the healing process of the scar; Like diabetes

Design outcomes

Primary

MeasureTime frame
Effectiveness of co2 laser fractional + PDL laser vs each one alone in terms of scar improvement. Timepoint: Before starting treatment, 40 days after the last treatment session. Method of measurement: Due to the Total Vancouver Scar Scale, color of the scar, vascular distribution of the scar, flexibility of the scar, height of the scar.;CO2 fractional laser + PDL safety in comparison with each alone in terms of scar improvement. Timepoint: 40 days after the last treatment session. Method of measurement: Prolonged pain or burning, prolonged redness or erythema, post-inflammatory hyperpigmentation (PIH) and even laser site infection.

Secondary

MeasureTime frame
Patient's satisfaction with the outcome of treatment. Timepoint: 40 days after the last visit. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaedeh Karimi Kivi

Iran University of Medical Sciences

maedeh.karimi100@yahoo.com+98 21 2207 4375

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026